
|Videos|December 16, 2015
How Renal Function Affects NOAC Dosing
Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how a patient's renal function affects appropriate dosing of new oral anticoagulants.
Advertisement
Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how a patient’s renal function affects appropriate dosing of new oral anticoagulants.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expands Approval of Ferric Maltol to Adolescents, Addressing a Critical Gap in Iron Deficiency Care
2
FDA Approves First Oral GLP-1 for Weight Management
3
Reading Between the Codes: How Seemingly Unrelated Conditions May Signal Earlier Multiple Myeloma
4
Advancing Autonomous Medication Management With Next-Generation Dispensing Technology
5




































































































































































































